Yoshiaki Norimatsu

Prof. Yoshiaki Norimatsu

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2019 in Acta Cytologica
Verified
Journal Article
Closed access
PDF file
YNYoshiaki Norimatsu
Yoshiaki Norimatsu
KYKenji Yanoh
Kenji Yanoh
YHYasuo Hirai
Yasuo Hirai
TKTetsuji Kurokawa
Tetsuji Kurokawa
Tadao K KobayashiTadao K Kobayashi
Tadao K Kobayashi
Franco FulcinitiFranco Fulciniti
Franco Fulciniti
The adoption of endometrial cytology as a diagnostic procedure has been hampered in the past by difficulties arising in interpreting the cellular findings due to a number of factors (such as excess blood, cellular overlapping, and the complex physiology of endometrium). Recently, the use of liquid-based cytology (LBC), with its ability to remove blood and mucus and to distribute cells uniformly in a thin layer on the slide, has provided an opportunity to reevaluate the role of endometrial cytology. LBC samples are easier to screen compared to conventional ones, due to a smaller screening area and an excellent quality of cell preparations. LBC by using peculiar cytoarchitectural features is a useful tool in the cellular diagnosis and follow-up of abnormalities, which, however, remains complementary to histopathology and to the emerging molecular diagnostic cytopathology. This review discusses these various entities and takes into consideration the ancillary techniques that may be useful in the diagnostic procedure. Herein, we also summarize the process and rationale by which updates were made to the standardized terminology in 2018 and outline the contents of the new Bethesda-style classification (the Yokohama system) for the endometrial cytology.

26 September 2012 in BMC Cell Biology
Verified
Journal Article
Open access
PDF file
ANAtsushi Nakamura
Atsushi Nakamura
JAJunichi Aizawa
Junichi Aizawa
KSKenshi Sakayama
Kenshi Sakayama
TKTeruki Kidani
Teruki Kidani
TTTomoyo Takata
Tomoyo Takata
HMHiroshi Masuno
Hiroshi Masuno
Background: One of the problems associated with osteosarcoma is the frequent formation of micrometastases in the lung prior to diagnosis because the development of metastatic lesions often causes a fatal outcome. Therefore, the prevention of pulmonary metastases during the early stage of tumor development is critical for the improvement of the prognosis of osteosarcoma patients. In Japan, soy is consumed in a wide variety of forms, such as miso soup and soy sauce. The purpose of this study is to investigate the effect of genistein, an isoflavone found in soy, on the invasive and motile potential of osteosarcoma cells. Methods: LM8 cells were treated for 3 days with various concentrations of genistein. The effect of genistein on cell proliferation was determined by DNA measurement in the cultures and 5-bromo-2’-deoxyuridine (BrdU) incorporation study. The assays of cell invasion and motility were performed using the cell culture inserts with either matrigel-coated membranes or uncoated membranes in the invasion chambers. The expression and secretion of MMP-2 were determined by immunohistochemistry and gelatin zymography. The subcellular localization and cellular level of β-catenin were determined by immunofluorescence and Western blot. For examining cell morphology, the ethanol-fixed cells were stained with hematoxylin-eosin (H&E). The expression of osteocalcin mRNA was determined by reverse transcription-polymerase chain reaction (RT-PCR). Results: Genistein dose-dependently inhibits cell proliferation. Genistein-treated cells were less invasive and less motile than untreated cells. The expression and secretion of MMP-2 were lower in the genistein-treated cultures than in the untreated cultures. β-Catenin in untreated cells was located in the cytoplasm and/or nucleus, while in genistein-treated cells it was translocated near to the plasma membrane. The level of β-catenin was higher in genistein-treated cells than in untreated cells. Treatment of LM8 cells with genistein induced morphological changes, markedly decreased the formation of multilayer masses of cells, and markedly increased the expression of osteocalcin mRNA. Conclusions: Genistein decreased invasive and motile potential by inducing cell differentiation in LM8 cells. Genistein may be useful as an anti-metastatic drug for osteosarcoma through its differentiation-inducing effects.

25 April 2016 in Cytopathology
Verified
Journal Article
Closed access
PDF file
YNYoshiaki Norimatsu
Yoshiaki Norimatsu
TYT. Yamaguchi
T. Yamaguchi
TTT. Taira
T. Taira
HAH. Abe
H. Abe
HSH. Sakamoto
H. Sakamoto
Tadao K KobayashiTadao K Kobayashi
Tadao K Kobayashi

26 September 2011 in Diagnostic Cytopathology
Verified
Journal Article
Closed access
PDF file
YNYoshiaki Norimatsu
Yoshiaki Norimatsu
HOHiroyuki Ohsaki
Hiroyuki Ohsaki
KYKenji Yanoh
Kenji Yanoh
NKNamiki Kawanishi
Namiki Kawanishi
Tadao K KobayashiTadao K Kobayashi
Tadao K Kobayashi

6 January 2019 in Cytopathology
Verified
Journal Article
Closed access
PDF file
YNYoshiaki Norimatsu
Yoshiaki Norimatsu
KYKenji Yanoh
Kenji Yanoh
YMYoshinobu Maeda
Yoshinobu Maeda
SISatoshi Irino
Satoshi Irino
YHYasuo Hirai
Yasuo Hirai
Tadao K KobayashiTadao K Kobayashi
Tadao K Kobayashi

13 August 2020 in Cytopathology
Verified
Journal Article
Closed access
PDF file
YNYoshiaki Norimatsu
Yoshiaki Norimatsu
SISatoshi Irino
Satoshi Irino
YMYoshinobu Maeda
Yoshinobu Maeda
KYKenji Yanoh
Kenji Yanoh
TKTetsuji Kurokawa
Tetsuji Kurokawa
FFFranco Fulciniti
Franco Fulciniti